Physician profile
Barry A Ross
NPI 1699714931
$1,499.58
in general payments reported to CMS, 2019-2025
12 companies · $104 in 2025
The $104 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $498 · 2021: $216 · 2022: $280 · 2023: $180 · 2024: $221 · 2025: $104.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $430 · Education: $74.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $430.21 |
| Education | $74.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $566.57 | 2019-2022 | |
| Abbvie INC. | $190.65 | 2019-2024 | |
| Medtronic, INC. | $188.59 | 2021-2023 | Gi Genius |
| Janssen Biotech, INC. | $175.19 | 2022-2024 | Stelara, Tremfya, Simponi Aria |
| Cerapedics INC. | $104.27 | 2025 | I-Factor Peptide Enhanced Bone Graft |
| Pfizer INC. | $77.09 | 2021-2024 | |
| Erbe USA INC | $74.68 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $45.04 | 2021-2024 | Entyvio |
| Olympus America INC. | $24.80 | 2021 | |
| Celgene Corporation | $23.67 | 2022 | |
| Merit Medical Systems INC | $14.83 | 2021 | |
| Intercept Pharmaceuticals, INC. | $14.20 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Barry Ross listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.